On 26 Feb 2020, Genmab A/S (GMAB) stock disclosed a move of -24.39% away from 50 day moving average and -17.42% away from 200 day moving average. Moving closer, we can see that shares have been trading -23.13% away off 20-day moving average. GMAB over recent time; they noted that 708678 shares changed at hands contradiction to its average trading volume of 373.75K. The stock changed -3.19% to recent value of $17.29. There are 649.11M shares outstanding and 642.72M shares are floated in market.
Analyst recommendations as reported on FINVIZ are rated on a 1 to 5 scale. 1 is equivalent to a Strong Buy rating, 3 a hold rating, and 5 a Strong Sell rating. The consensus recommendation is the average rating on a stock by the analyst community. Analyst mean recommendation for this stock stands at 1.8. A stock rating will usually tell the investor how well a stock’s market value relates to what analysts believe is a fair value for the stock, based on an objective evaluation of the company.
GMAB ’s shares are at -21.30% for the quarter and driving a 1.56% return over the course of the past year and is now at -22.57% since this point in 2019. The average volatility for the week and month was at -15.78% and -28.17% respectively.